Author details

Full Name

Rozita Bagheri-Yarmand

Affiliation

The University of Texas MD Anderson Cancer Center

ORCID

Career Start Year

1992

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35760800	Osteocyte CIITA aggravates osteolytic bone lesions in myeloma.	Nat Commun	2022
34249457	<i>ATF4</i> loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.	Am J Cancer Res	2021
33536187	ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>.	Mol Cancer Ther	2021
34638434	<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.	Cancers (Basel)	2021
32580150	HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs.	Endocr Relat Cancer	2020
30552230	Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer.	Mol Cancer Res	2019
30858546	Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.	Oncogene	2019
27935748	ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.	J Clin Endocrinol Metab	2017
25795775	A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.	J Biol Chem	2015
23722650	Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner.	Carcinogenesis	2013
20603326	Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A.	J Cell Biol	2010
20530685	Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.	Cancer Res	2010
20530684	Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.	Cancer Res	2010
17671172	Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.	Cancer Res	2007
17671180	Identification of Pax5 as a target of MTA1 in B-cell lymphomas.	Cancer Res	2007
16381000	LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.	Int J Cancer	2006
14760089	The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.	Clin Cancer Res	2004
15193260	Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.	Cancer Cell	2004
15226262	Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.	Development	2004
14749719	p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate.	EMBO Rep	2004
12732616	Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands.	J Cell Biol	2003
12912973	HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.	Clin Cancer Res	2003
14613024	Emerging roles of MTA family members in human cancers.	Semin Oncol	2003
12700278	Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).	Mol Cancer Ther	2003
12611881	Activating transcription factor 4 overexpression inhibits proliferation and differentiation of mammary epithelium resulting in impaired lactation and accelerated involution.	J Biol Chem	2003
12167865	A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.	Nature	2002
12374700	Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.	Clin Cancer Res	2002
11146623	Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.	Nat Cell Biol	2001
11299764	Breast carcinoma cell uptake and biodistribution of technetium-99m-carboxymethyl benzylamide dextran.	Anticancer Res	2001
11382770	Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells.	J Biol Chem	2001
11410523	Carboxymethyl benzylamide dextran and tamoxifen combination inhibits tumor growth and angiogenesis.	Clin Cancer Res	2001
11514538	Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF(165) and VEGF(165).KDR Complexes.	J Biol Chem	2001
11121407	Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function.	J Biol Chem	2001
10967114	Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis.	J Biol Chem	2000
9973189	Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice.	Cancer Res	1999
10353261	Effects of the binding of a dextran derivative on fibroblast growth factor 2: secondary structure and receptor-binding studies.	Biochem Pharmacol	1999
9662260	The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).	Br J Cancer	1998
9663468	Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.	Cell Growth Differ	1998
9066661	Modulations of breast fibroblast and carcinoma cell interactions by a dextran derivative (CMDB7).	Anticancer Res	1997
9344845	Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): interference with the FGF2 autocrine loop [corrected].	Biochem Biophys Res Commun	1997
7534590	Carboxymethyl benzylamide dextrans inhibit breast cell growth.	In Vitro Cell Dev Biol Anim	1994
1280032	Inhibitory effects of dextran derivatives in vitro on the growth characteristics of premalignant and malignant human mammary epithelial cell lines.	Anticancer Res	1992

1 - 42 of 42

Yong Pan

The University of Texas MD Anderson Cancer Center

Career Start Year 2002

Number of shared co-authors 2

Joshua Chuck Harrell

Virginia Commonwealth University

Career Start Year 2002

Number of shared co-authors 0

Limei Hu

Aier Eye Hospital of Wuhan University

Career Start Year 2001

Number of shared co-authors 2

Kristiina Iljin

VTT Technical Research Centre of Finland Ltd

Career Start Year 1999

Number of shared co-authors 0

Alana L Welm

Huntsman Cancer Institute, University of Utah

Career Start Year 1999

Number of shared co-authors 1

Jianjun Shen

The University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 3

Yaoqi Alan Wang

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 3

Jun Yao

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 7

Theresa M LaVallee

Parker Institute for Cancer Immunotherapy

Career Start Year 1996

Number of shared co-authors 0

Hai Hu

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Career Start Year 1996

Number of shared co-authors 0

Zhaomei Mu

Thomas Jefferson University Hospital

Career Start Year 1994

Number of shared co-authors 0

Paul N Span

Radboud University Medical Center

Career Start Year 1993

Number of shared co-authors 1

Senthil K Muthuswamy

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1992

Number of shared co-authors 1

Barry R Davies

Oncology R&D

Career Start Year 1992

Number of shared co-authors 0

Maria Lucia Hirata Katayama

School of Medicine of Sao Paulo University

Career Start Year 1991

Number of shared co-authors 0

Kornelia Polyak

Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School

Career Start Year 1991

Number of shared co-authors 1

Powel H Brown

The University of Texas MD Anderson Cancer Center

Career Start Year 1991

Number of shared co-authors 4

Aykut Uren

Georgetown University Medical Center

Career Start Year 1991

Number of shared co-authors 0

Ben Ho Park

Vanderbilt University Medical Center

Career Start Year 1990

Number of shared co-authors 0

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 7

Eldad Zacksenhaus

University of Toronto

Career Start Year 1988

Number of shared co-authors 1

Alfredo A Molinolo

University of California

Career Start Year 1984

Number of shared co-authors 1

John A Copland

Mayo Clinic Jacksonville

Career Start Year 1982

Number of shared co-authors 1

Adrian L Harris

University of Oxford

Career Start Year 1981

Number of shared co-authors 2

Patricia S Steeg

Center for Cancer Research, National Cancer Institute

Career Start Year 1980

Number of shared co-authors 1

Fabien Calvo

Universite de Paris-Cite

Career Start Year 1979

Number of shared co-authors 0

Stanley Lipkowitz

Center for Cancer Research, National Cancer Institute

Career Start Year 1978

Number of shared co-authors 1

Christopher C Benz

Buck Institute for Research on Aging

Career Start Year 1977

Number of shared co-authors 2

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Career Start Year 1976

Number of shared co-authors 15

Dennis J Slamon

David Geffen School of Medicine at university of california los angeles

Career Start Year 1973

Number of shared co-authors 2

row(s) 1 - 30 of 30

Rakesh Kumar

Rutgers New Jersey Medical School

Co-authored papers 19

Robert F Gagel

The University of Texas MD Anderson Cancer Center

Co-authored papers 8

Michelle D Williams

The University of Texas M. D. Anderson Cancer Center

Co-authored papers 5

Krishna M Sinha

The University of Texas MD Anderson Cancer Center

Co-authored papers 3

Liana Adam

The University of Texas MD Anderson Cancer Center

Co-authored papers 3

Gilbert J Cote

The University of Texas MD Anderson Cancer Center Houston

Co-authored papers 3

Anupama E Gururaj

National Institute of Allergy and Infectious Disease, National Institutes of Health

Co-authored papers 3

Matthew D Ringel

The Ohio State University College of Medicine and Comprehensive Cancer Center

Co-authored papers 2

Gabriel N Hortobagyi

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Yue Lu

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Kelly K Hunt

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Kenna R Mills Shaw

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Yasmeen Q Rizvi

University of Texas MD Anderson Cancer Center

Co-authored papers 2

Su-Chen Huang

Industrial Technology Research Institute

Co-authored papers 1

Adel K El-Naggar

MD Anderson Cancer Center

Co-authored papers 1

Rohinton S Tarapore

Co-authored papers 1

Pei Lin

Co-authored papers 1

John E Ladbury

University of Leeds

Co-authored papers 1

Nora M Navone

MD Anderson Cancer Center

Co-authored papers 1

Brian J Haas

Broad Institute of MIT and Harvard

Co-authored papers 1

Joshua E Allen

Co-authored papers 1

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 1

Subrata Sen

UT MD Anderson Cancer Center

Co-authored papers 1

Jiannis Ragoussis

McGill University

Co-authored papers 1

Funda Meric-Bernstam

University of Texas MD Anderson Cancer Center

Co-authored papers 1

Zamal Ahmed

The University of Texas MD Anderson Cancer Center